Viewing Study NCT00684294


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-01-06 @ 1:12 PM
Study NCT ID: NCT00684294
Status: TERMINATED
Last Update Posted: 2020-03-02
First Post: 2008-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Sponsor:
Organization: